Iofina PLC (DE:IF7)
FRANKFURT:IF7
IF7 Stock Chart & Stats
€0.32
<€0.01(2.88%)
At close: 4:00 PM EST
€0.32
<€0.01(2.88%)
Day’s Range― - ―
52-Week Range€0.22 - €0.62
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€108.90M
Enterprise Value€122.57M
Total Cash (Recent Filing)€11.74M
Total Debt (Recent Filing)€6.66M
Price to Earnings (P/E)1568.4
Beta0.48
Next Earnings
Sep 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.04
Shares Outstanding191,858,400
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio4.73
Price to Book (P/B)121.65
Price to Sales (P/S)99.79
P/FCF Ratio2.66K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.70Price Target Upside117.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)<0.01
Revenue Forecast (FY)€815.52K
Bulls Say, Bears Say
Bulls Say
Production & Revenue GrowthSustained, multi-year volume growth demonstrates scalable upstream operations and growing market share in a global iodine market ~40k t. Higher volumes support durable revenue expansion, improve fixed-cost absorption, and underpin management's step-up to ~1,000 t run-rate and longer-term scale economics.
Conservative Balance SheetLow leverage and growing equity provide financial flexibility to fund expansion and absorb operational volatility. The company entered expansion with net cash and modest bank debt, reducing refinancing risk and enabling selective use of facilities for growth without immediate solvency pressure.
Execution Track Record & Clear Growth RoadmapConsistent on-time, on-budget project delivery shows capable operations and project management, validating unit economics and supporting repeatable rollouts. A clear, staged roadmap to 2,000 tpa gives investors visibility into scale gains and future margin improvement if execution continues.
Bears Say
Rising CapEx & Financing RiskA large, near-term jump in capex increases execution and financing risk. If project timing, yields, or iodine prices falter, the need to deploy ~$45m and draw bank facilities could pressure liquidity, elevate leverage and constrain flexibility during the multi-year build-out.
Working Capital & Receivable VolatilityLumpy, elevated receivables create cash conversion uncertainty and can magnify funding needs during rapid scale-up. Working-capital swings can convert strong operating profits into weak free cash flow, forcing reliance on external funding or delaying reinvestment.
Margin & Free Cash Flow VolatilityPersistent volatility in free cash flow and margins limits the company's ability to self-fund expansion reliably. Variable FCF reflects capex and working-capital swings; this undermines predictability of returns and increases execution risk as management scales production.
Iofina plc News
IF7 FAQ
What was Iofina PLC’s price range in the past 12 months?
Iofina PLC lowest stock price was €0.22 and its highest was €0.62 in the past 12 months.
What is Iofina PLC’s market cap?
Iofina PLC’s market cap is €108.90M.
When is Iofina PLC’s upcoming earnings report date?
Iofina PLC’s upcoming earnings report date is Sep 18, 2026 which is in 83 days.
How were Iofina PLC’s earnings last quarter?
Iofina PLC released its earnings results on Apr 30, 2026. The company reported €0.024 earnings per share for the quarter, beating the consensus estimate of N/A by €0.024.
Is Iofina PLC overvalued?
According to Wall Street analysts Iofina PLC’s price is currently Undervalued.
Does Iofina PLC pay dividends?
Iofina PLC does not currently pay dividends.
What is Iofina PLC’s EPS estimate?
Iofina PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Iofina PLC have?
Iofina PLC has 191,858,400 shares outstanding.
What happened to Iofina PLC’s price movement after its last earnings report?
Iofina PLC reported an EPS of €0.024 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.676%.
Which hedge fund is a major shareholder of Iofina PLC?
Currently, no hedge funds are holding shares in DE:IF7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Iofina plc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
40.00%
12-Months-Change
Fundamentals
Return on Equity
14.89%
Trailing 12-Months
Asset Growth
15.62%
Trailing 12-Months
Company Description
Iofina PLC
Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offers iodides, chlorides, and fluorides; and iodine used for animal care and health, biocides and catalysts, disinfectants, fungicide, specialty intermediates, mineral separators, thyroid health, wound healing, diagnostic imaging, iofina logo gray sun 5, preservatives and sanitizers, semiconductor etchant gas, soil fumigants, fine halogen chemicals, electronic specialty gases, and heat stabilizers applications. The company markets its products in electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, nylon, x-ray contrast media industries. It serves animal nutrition, biocidal paints and coatings, disinfectants, x-ray contrast media, pharmaceuticals, electronics, perovskites for solar, optical polarizing films, industrial, oil and gas industries. The company sells its products under the IOflo and IOprill brand names. Iofina plc was incorporated in 2005 and is based in London, the United Kingdom.
IF7 Stock 12 Month Forecast
Average Price Target
€0.70
▲(117.70% Upside)